Home Where We Practice Atypical Models New Study Examines Effect of Atropine Treatment in Childhood Myopia

New Study Examines Effect of Atropine Treatment in Childhood Myopia

Vanderbilt University is one of 10 sites selected by the Pediatric Eye Disease Investigator Group to be part of a study to determine the effectiveness of atropine drops in slowing the progression of myopia. Participants will be randomly assigned to daily atropine or placebo for 24 months, followed by six months off treatment.

Lori Ann Kehler, OD, assistant professor of ophthalmology and division chief of optometry at Vanderbilt, says, “There is a lot of interest in this particular study. If using these drops works, it will completely change our practice and the ability to impact a child’s vision for their lifetime.”

According to a news article from Vanderbilt, the U.S. trial is based on the positive outcomes of recent studies, which determined that atropine eye drops decreased the progression of myopia in Asia. “In the Asian studies, the use of a lower dose was effective in slowing the progression of myopia. It was a totally unexpected result and gives us a lot of enthusiasm for its success as an option for treatment,” Dr. Kehler says.

Click here to read more from WO on myopia control.

- Advertisment -

Most Popular

Women In The News – August

Women In Optometry regularly recognizes the accomplishments of women ODs in the profession and in their communities. Have you stepped into a new leadership role...

August Lineup of New Frames Offerings Bring Style and Comfort for Summer

The McGee Group announces new releases from its family of partner brands, including Life is Good, Mr Turk, Totally Rimless and XOXO. These well-known...

Half-mile Office Relocation Makes a World of a Difference

The week of July 11, 2022, Marianne McDaniel, OD, closed to relocate Mascoutah Eye Care from its original location to its new home just...

Business Blossoms Over Decade from One Cold Start to Three Offices

2022 has been a year of change and new beginnings for Mary Demirjian, OD, and her practice. In March, she relocated her Encino, California,...